Gross Hematuria and Prostatic Cancer in Libyan Patients
Abdsalme Elhony
Department of Pathology, Faculty of Medicine, Benghazi University, Benghazi, Libya.
Tarik El. Darat
Department of Pathology, Faculty of Medicine, Benghazi University, Benghazi, Libya.
Raouf Elkawafi
Department of Pathology, Faculty of Medicine, Benghazi University, Benghazi, Libya.
Walid Ramse
Department of Pathology, Faculty of Medicine, Benghazi University, Benghazi, Libya.
Adem Ibrahim Alzaghad
Department of Pathology, Faculty of Medicine, Benghazi University, Benghazi, Libya.
Dhastagir Sultan Sheriff *
Department of Biochemistry, Faculty of Medicine, Benghazi University, Benghazi, Libya.
*Author to whom correspondence should be addressed.
Abstract
Aim: Gross hematuria due to prostate cancer is an important clinical presentation and it is necessary to collect, analyze and determine certain criteria and data in the diagnosis and management of prostatic cancer. The aim of the present study is to find out the frequency of gross hematuria and to correlate it with gross hematuria and serum Prostatic Specific Antigen (PSA).in prostatic cancer patients.
Materials and Methods: A retrospective study was done in patients diagnosed with prostatic cancer in Hawari center for urology in Benghazi Libya from 2011 up to 2017. 60 cases were taken for the present study. The data such as age of the patient, first complaint such as gross hematuria, serum PSA levels, histopathology result, the types of therapy received (medical or surgical) were analyzed from these Libyan patients.
Results: 25 percent cases in the present study had gross hematuria and there was positive correlation between gross hematuria, serum PSA levels and Gleason score.
Conclusion: The result of this study indicate that the presentation of hematuria is not uncommon in prostate cancer. Therefore, it may be necessary to estimate serum PSA levels and do digital rectal examination (DRE) for men aged between 50-70 years old for early diagnosis and management of prostate cancer.
Keywords: Prostate cancer, hematuria, PSA, Gleason score.